Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott(St. Jude Children's Research Hospital), Jaroslav Štěrba(Masaryk University), Cynthia C. Bartholomae(German Cancer Research Center), David Shih(University of Toronto), Charles D. Imbusch(German Cancer Research Center), Gary D. Bader(University of Toronto), Ursula Weber(German Cancer Research Center), Dominik Sturm(German Cancer Research Center), Nicolle Diessl(German Cancer Research Center), Stefan Wiemann(German Cancer Research Center), Linda Linke(German Cancer Research Center), Péter Hauser(Buda Health Center), Lourdes Adriana Esparza(Sanford Burnham Prebys Medical Discovery Institute), Peter Siesjö(Lund University), Anna Darabi(Lund University), Marina Ryzhova(German Cancer Research Center), Serap Erkek(Izmir University), Benjamin Raeder(European Molecular Biology Laboratory), Florence M.G. Cavalli(Hospital for Sick Children), Stephan Wolf(German Cancer Research Center), Laura Sieber(German Cancer Research Center), Eszter Turányi(Semmelweis University), Fabian Kratochwil(German Cancer Research Center), Huriye Seker‐Cin(German Cancer Research Center), Sebastian Stark(German Cancer Research Center), Marc Remke(Saarland University), Emma Sandén(Lund University), Benedikt Brors(German Cancer Research Center), Marc Zapatka(German Cancer Research Center), Hans-Jörg Warnatz(Max Planck Institute for Molecular Genetics), Thomas Zichner(German Cancer Research Center), Daisuke Kawauchi(German Cancer Research Center), Scott Zuyderduyn(University of Toronto), Ivo Buchhalter(German Cancer Research Center), Marcel Kool(German Cancer Research Center), Gideon Zipprich(German Cancer Research Center), Volker Hovestadt(Broad Institute), Christof von Kalle(Luxembourg Institute of Health), Wei Wang(German Cancer Research Center), David Jones(German Cancer Research Center), Thomas S. Risch(Max Planck Institute for Molecular Genetics), Chris Lawerenz(German Cancer Research Center), Natalie Jäger(German Cancer Research Center), Andrea Wittmann(German Cancer Research Center), Adrian M. Stütz(Winterthur Museum Garden and Library), Marie-Laure Yaspo(Max Planck Institute for Molecular Genetics), Sabine Schmidt(Bernhard Nocht Institute for Tropical Medicine), Scott R. VandenBerg(University of California San Diego), Catherine Lee(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 674
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k